The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network von Terpos, E., Sezer, O., Croucher, P.I., García-Sanz, R., Boccadoro, M., San Miguel, J., Ashcroft, J., Bladé, J., Cavo, M., Delforge, M., Dimopoulos, M.-A., Facon, T., Macro, M., Waage, A., Sonneveld, P.

Volltext

Myeloma bone disease: pathophysiology and management von Terpos, E., Dimopoulos, M.-A.

Volltext

Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up von Moreau, P., San Miguel, J., Sonneveld, P., Mateos, M.V., Zamagni, E., Avet-Loiseau, H., Hajek, R., Dimopoulos, M.A., Ludwig, H., Einsele, H., Zweegman, S., Facon, T., Cavo, M., Terpos, E., Goldschmidt, H., Attal, M., Buske, C.

Volltext

Pathogenesis and treatment of renal failure in multiple myeloma von Dimopoulos, M A, Kastritis, E, Rosinol, L, Bladé, J, Ludwig, H

Volltext

Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid von Dimopoulos, M.A., Kastritis, E., Bamia, C., Melakopoulos, I., Gika, D., Roussou, M., Migkou, M., Eleftherakis-Papaiakovou, E., Christoulas, D., Terpos, E., Bamias, A.

Volltext

New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) von Ocio, E M, Richardson, P G, Rajkumar, S V, Palumbo, A, Mateos, M V, Orlowski, R, Kumar, S, Usmani, S, Roodman, D, Niesvizky, R, Einsele, H, Anderson, K C, Dimopoulos, M A, Avet-Loiseau, H, Mellqvist, U-H, Turesson, I, Merlini, G, Schots, R, McCarthy, P, Bergsagel, L, Chim, C S, Lahuerta, J J, Shah, J, Reiman, A, Mikhael, J, Zweegman, S, Lonial, S, Comenzo, R, Chng, W J, Moreau, P, Sonneveld, P, Ludwig, H, Durie, B G M, Miguel, J F S

Volltext

Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents von Dimopoulos, M.A., Delimpasi, S., Katodritou, E., Vassou, A., Kyrtsonis, M.C., Repousis, P., Kartasis, Z., Parcharidou, A., Michael, M., Michalis, E., Gika, D., Symeonidis, A., Pouli, A., Konstantopoulos, K., Terpos, E., Kastritis, E.

Volltext

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma von Dimopoulos, M A, Chen, C, Spencer, A, Niesvizky, R, Attal, M, Stadtmauer, E A, Petrucci, M T, Yu, Z, Olesnyckyj, M, Zeldis, J B, Knight, R D, Weber, D M

Volltext

Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up von Kastritis, E, Leblond, V, Dimopoulos, M A, Kimby, E, Staber, P, Kersten, M J, Tedeschi, A, Buske, C

Volltext

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma von Palumbo, A, Rajkumar, S V, Dimopoulos, M A, Richardson, P G, San Miguel, J, Barlogie, B, Harousseau, J, Zonder, J A, Cavo, M, Zangari, M, Attal, M, Belch, A, Knop, S, Joshua, D, Sezer, O, Ludwig, H, Vesole, D, Bladé, J, Kyle, R, Westin, J, Weber, D, Bringhen, S, Niesvizky, R, Waage, A, von Lilienfeld-Toal, M, Lonial, S, Morgan, G J, Orlowski, R Z, Shimizu, K, Anderson, K C, Boccadoro, M, Durie, B G, Sonneveld, P, Hussein, M A

Volltext

Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide... von Terpos, E., Kastritis, E., Christoulas, D., Gkotzamanidou, M., Eleutherakis-Papaiakovou, E., Kanellias, N., Papatheodorou, A., Dimopoulos, M.A.

Volltext

The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma von Terpos, E, Dimopoulos, M-A, Sezer, O

Volltext

International Myeloma Working Group recommendations for global myeloma care von Ludwig, H, Miguel, J S, Dimopoulos, M A, Palumbo, A, Garcia Sanz, R, Powles, R, Lentzsch, S, Ming Chen, W, Hou, J, Jurczyszyn, A, Romeril, K, Hajek, R, Terpos, E, Shimizu, K, Joshua, D, Hungria, V, Rodriguez Morales, A, Ben-Yehuda, D, Sondergeld, P, Zamagni, E, Durie, B

Volltext

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2 von Gavalas, N G, Tsiatas, M, Tsitsilonis, O, Politi, E, Ioannou, K, Ziogas, A C, Rodolakis, A, Vlahos, G, Thomakos, N, Haidopoulos, D, Terpos, E, Antsaklis, A, Dimopoulos, M A, Bamias, A

Volltext

European Myeloma Network guidelines for the management of multiple myeloma-related complications von Terpos, Evangelos, Kleber, Martina, Engelhardt, Monika, Zweegman, Sonja, Gay, Francesca, Kastritis, Efstathios, van de Donk, Niels W C J, Bruno, Benedetto, Sezer, Orhan, Broijl, Annemiek, Bringhen, Sara, Beksac, Meral, Larocca, Alessandra, Hajek, Roman, Musto, Pellegrino, Johnsen, Hans Erik, Morabito, Fortunato, Ludwig, Heinz, Cavo, Michele, Einsele, Hermann, Sonneveld, Pieter, Dimopoulos, Meletios A, Palumbo, Antonio

Volltext

Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian So... von Bringhen, S., Milan, A., D'Agostino, M., Ferri, C., Wäsch, R., Gay, F., Larocca, A., Offidani, M., Zweegman, S., Terpos, E., Goldschmidt, H., Cavo, M., Ludwig, H., Driessen, C., Auner, H. W., Caers, J., Gramatzki, M., Dimopoulos, M. A., Boccadoro, M., Einsele, H., Sonneveld, P., Engelhardt, M.

Volltext

Mechanisms of bone destruction in multiple myeloma von Terpos, E., Christoulas, D., Gavriatopoulou, M., Dimopoulos, M.A.

Volltext

How we treat endocrine complications of immune checkpoint inhibitors von Paschou, S.A., Stefanaki, K., Psaltopoulou, T., Liontos, M., Koutsoukos, K., Zagouri, F., Lambrinoudaki, I., Dimopoulos, M.-A.

Volltext

Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement von Dimopoulos, M A, Palumbo, A, Attal, M, Beksaç, M, Davies, F E, Delforge, M, Einsele, H, Hajek, R, Harousseau, J-L, da Costa, F Leal, Ludwig, H, Mellqvist, U-H, Morgan, G J, San-Miguel, J F, Zweegman, S, Sonneveld, P

Volltext

Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy von Liontos, M, Andrikopoulou, A, Koutsoukos, K, Markellos, C, Skafida, E, Fiste, O, Kaparelou, M, Thomakos, N, Haidopoulos, D, Rodolakis, A, Dimopoulos, M A, Zagouri, F

Volltext